Chondrocyte preparation with the safety and efficiency is the first step in cartilage regenerative medicine. To prepare a chondrocyte proliferation medium that does not contain fetal bovine serum (FBS) and that provides more than a 1000-fold increase in cell numbers within approximately 1 month, we attempted to use the medium containing 5% human serum (HS), but it exerted no more than twofold increase in 2 weeks. To compensate for the limited proliferation ability in HS, we investigated the combinational effects of 12 factors [i.e., fibroblast growth factor(FGF)-2, insulin-like growth factor(IGF)-I, insulin, bone morphogenetic protein-2, parathyroid hormone, growth hormone, dexamethasone, 1α25-dihydroxy vitamin D 3 , L-3,3′,5′-triodothyronine, interleukine-1 receptor antagonist, 17β-estradiol, and testosterone] on the proliferation of human auricular chondrocytes by analysis of variance in fractional factorial design. As a result, FGF-2, dexamethasone, insulin, and IGF-I possessed promotional effects on proliferation, while the combination of FGF-2 with insulin or IGF-I synergistically enhanced the proliferation. Actually, the chondrocytes increased 7.5-fold in number in 2 weeks in a medium containing 5% HS with 10 ng/ml FGF-2 , while the cell number synergistically gained a 10-12-fold increase with 5 µg/ml insulin or 100 ng/ml IGF-I in the same period. The proliferation effects were more enhanced at a concentration of 100 ng/ml for FGF-2, and especially for the combination of 100 ng/ml FGF-2 and 5 µg/ml insulin (approximately 16-fold within 2 weeks). In the long-term culture with repeated passaging, this combination provided more than 10,000-fold within 8 weeks (i.e., passage 4). Thus, we concluded that such a combination of FGF-2 with insulin or IGF-I may be useful for promotion of auricular chondrocyte proliferation in a clinical application for cartilage regeneration.
INTRODUCTION
tion of defective or injured body parts. This new approach is anticipated to overcome the difficulties or problems in the present clinical treatment. Recently, the Tissue engineering is a challenging technology in which the tissues or the cells are cultured in the laborastudies on tissue engineering have endeavored to grow every type of human tissue: liver, bone, muscle, cartitory and are used for replacement or support of the func- lage, blood vessels, heart muscles, nerves, pancreatic isfractional factorial design" (8) , the effects of the individual factors and the synergy of combinations were evalulets, and more. Among them, cartilage regenerative medicine has progressed well. Tissue-engineered cartiated. This statistical method is useful when the number of potential factors is large, because it can minimize the lage has already been available for clinical use in the treatment of patients with joint defects (5, 22, 23) or for total numbers of runs required. According to this method, we selected highly effective combinations of soluble the correction of vesicoureteral reflux (6) .
However, to broaden the indication range of cartilage factors for proliferation of human auricular chondrocytes, which might be immediately applied in the cliniregenerative medicine (e.g., to microtia, which is a congenital anomaly of the ear, cleft lip and palate, or osteocal field. arthritis), some improvement would be necessary. One
MATERIALS AND METHODS of issues to be improved is cell preparation with safety
Growth Factors and Reagents and efficiency. We should obtain a sufficient cell number from a small volume of specimen within a limited Dulbecco's modified Eagle's medium (DMEM), period, for clinical use. In a previous report on autologous DMEM nutrient mixture F-12 HAM (DMEM/F12), penchondrocyte transplantation for joint defects, a culture meicillin-streptomycin solution, trypsin-EDTA solution, fedium with 10% autologous human serum provided aptal bovine serum (FBS), and human serum (HS, lot# proximately 5 × 10 6 cells within 3 weeks, corresponding 043K0500, 043K0501, and 043K0502) were purchased to 0.3-0.4 ml of regenerative cartilage material (23).
from Sigma Chemical Co. (St. Louis, MO, USA). DexaHowever, because the volume of the regenerative cartimethasone (Dex), 1α25-dihydroxy vitamin D 3 (vitD), Llage needed in the treatment of microtia or end-stage 3,3′,5′-triiodothyronine (T3), and 17β-estradiol (E 2 ) were osteoarthritis of knees may be some tens of milliliters, from EMD Bioscience (San Diego, CA, USA). Collamore than a 100-fold increase in cell numbers would genase from Clostridium histolyticum and ISOGEN need to be prepared for such cases, compared with that were from Wako Pure Chemical Industries, Ltd. (Osaka, in an autologous transplantation. Japan). Other reagents were: atelocollagen (Kawaken Fine To improve the efficiency of cell preparation, many Chemicals Co., Ltd., Tokyo, Japan), bullet kit chondroresearchers have attempted to use growth factors with cyte growth medium (CGM, Cambrex Bioscience Walkfetal bovine serum (FBS). Quatela and coworkers examersville, Inc., Walkersville, MD, USA), FGF-2 (kindly ined the proliferation of human auricular chondrocytes provided by Kaken Pharmaceutical Corporation, Ltd., in DMEM containing 5% FBS with 10 ng/ml fibroblast Tokyo, Japan), recombinant human insulin-like growth growth factor (FGF)-2 and 3 ng/ml transforming growth factor-I (IGF-I, former Genzyme-Techne, Minneapolis, factor (TGF)-β, which exerted a maximal synergistic ef-MN), insulin (MP Biomedicals Inc., Irvine, CA, USA), fect on thymidine uptake (25).
recombinant human bone morphogenetic protein-2 (BMPAlthough FBS contains various factors that can in-2, kindly provided by Yamanouchi Pharmaceutical Co., crease chondrocyte proliferation (7, 10) , the use of FBS Ltd., Tokyo, Japan), human parathyroid hormone [PTH may be restricted for clinical application because it in-(1-34), Anaspec, Inc., San Jose, CA], human growth cludes the risk for transmission of viral and other pathohormone (GH, Biogenesis, Ltd., Poole, UK), recombigens. In addition, problems of possible immune reaction nant human interleukin-1 receptor antagonist (IL-1 RA, against bovine protein in the serum should be considered Strathmann Biotech GmbH, Hamburg, Germany), and when the regenerated tissues cultured in the FBS-contained testosterone (Ultrafine Chemicals, Manchester, UK). medium are transplanted into humans. The previous studCell Isolation ies had shown immune response by antibody detection against bovine serum proteins in burn patients receiving All procedures of the present experiments were approved by the ethic committee of the University of keratinocyte grafts cultured from FBS (12, 19) .
Under clinical conditions, we may use human serum Tokyo Hospital (ethic permission #622). Remnant auricular cartilage and surgical debris of the costal cartilage (HS) obtained from the patients by autologous blood transfusion, which would help the proliferation of their were obtained from five children (age range 10-15 years) who underwent microtia surgery at the University of own cells. With HS, we statistically examined the additional effectiveness of soluble factors with regard to their Tokyo Hospital, with informed consent. The perichondrium was separated from the auricular cartilage under synergy in chondrocytes obtained from the patients. For this experiment, we chose 12 kinds of soluble factors, sterile conditions, while that of the costal cartilage had been already removed during the operation. The isolated all of which possess some effect on chondrocyte proliferation or differentiation and are clinically available becartilage was minced into 1-mm 3 pieces and digested with 0.15% collagenase in DMEM containing penicillin cause their safety has already been secured. Using the statistical method that is termed "analysis of variance by and streptomycin at 37°C for 24 h. The digested suspen-sion was filtered using a sterile 100-µm nylon cell eration. The doses of each factor were used from previous papers or were determined as their modifications strainer (BD Falcon, Bedford, MA, USA) and centrifuged at 430 × g for 5 min. The resulting pellet of cells due to our own preliminary data and/or economical reasons (Table 1) . With the usual factorial design, 2 12 = was washed twice with DMEM containing the antibiotics and then resuspended in the medium. The number 4096 treatment combinations would be needed, but this is practically impossible. We adopted fractional factorial of cells was calculated using a hemocytometer, and the viability of the cells was determined using trypan blue design (8) to reduce the experimental units to a practical number of 256 combinations. This design retains good vital dye.
statistical properties and has found its greatest use in Chondrocyte Culture and Evaluation of Proliferation industrial research. We used the software JMP-5.1.1J (SAS Institute, Inc., Cary, NC, USA) to generate the 256 Chondrocytes were suspended in 0.24% atelocollagen solution (pH 7). The mixture was placed in each well of kinds of randomized combinations in which those 12 factors independently appeared on the incidence of 50% a six-well plate at 2 ml, or a 96-well plate for 0.1 ml, at a density of 2 × 10 4 cells/ml. The atelocollagen formed ( Table 2 ). We then made the same number of media containing DMEM/F-12 with those combinations of faca gel in 1-h incubation at 37°C, embedding the cells in a 3D condition. The commercial medium, CGM containtors and 5% HS. Three kinds of auricular chondrocytes obtained from different patients were incubated in each ing 5% FBS with an undisclosed concentration of FGF-2, IGF-I, and insulin, or the medium containing DMEM/ well of 96-well plates with those media for 2 weeks. The effects of each medium on proliferation were exam-F-12 with or without serum and/or soluble factors was gently poured on the gel at a volume of 2 ml or 0.1 ml, ined in the colorimetric assay for cell proliferation. Values for three kinds of auricular chondrocytes in each respectively, in a 37°C/5% CO 2 incubator. Throughout the experiment, the medium was changed three times media were processed by analysis of variance using the software JMP, providing an F-value, meaning the effects per week. To release the cells, the gel was incubated in 0.3% collagenase at 37°C for 2 h. of the individual factors or the interaction terms of two factors, as well as a parameter estimate indicating exTo evaluate the cell proliferation by cell count, the auricular chondrocytes (cultured in CGM, passage 4) pected changes produced by one factor or two. Total effect of two factors on proliferation was compared with from the five patients were individually incubated in five wells of a six-well plate for each medium. After a each other, as the sum of parameter estimates of two main effects and interaction. 2-week incubation, the cell numbers were counted by a hematocytometer, while the viability of cells was checked
Total RNA Extraction and Real-Time PCR by trypan blue staining. For the long-term culture with repeated passaging of the auricular or costal chondroThe chondrocytes were released from the atelocollagen gel by a 30-min incubation in 0.3% collagenase. cytes, we cultured the cells in three wells of six-well plates with the CGM or the DMEM/F-12 with 5% HS The total RNA was isolated from the chondrocytes with ISOGEN following the supplier's protocol. Complemenand soluble factors. Passage was performed every week or every other week, while the mean cell numbers in the tary DNA (cDNA) was synthesized from 1 µg of total three wells were counted during every passage.
To evaluate the samples on the 96-well plates, we used a colorimetric assay for cell proliferation, Cell Pro- cytes from the gel in each well of the 96-well plates, the cells were centrifuged for 5 min at 430 × g and sepa-FGF-2 10 ng/ml 13 rated from the supernatant, which was then removed.
IGF-I 100 ng/ml 30
The labeling mixture was then added to the cells, which RNA with the Superscript II reverse transcriptase kit (In-IGF-I, whose combination had been known to increase the proliferation in a previous paper (42), little proliferavitrogen, Carlsbad, CA, USA). For the real-time PCR, the ABI Prism Sequence Detection System 7000 was used.
tion was noted (Fig. 2, open bar) . In contrast, HS may have some effects on the proliferation of auricular chonPrimers were designed based on the sequences obtained from the GenBank, and amplicons of 50-250 base pairs drocytes, but it provided no more than twofold in 2 weeks (Fig. 2, filled bar) . FBS showed better proliferawith a melting temperature of between 55°C and 60°C were selected. Aliquots of the first-strand cDNA (1 µg)
tion of approximately threefold within 2 weeks (Fig. 2 , filled bar). When FGF-2 and IGF-I were added to the were amplified with the QuantiTect SYBER Green PCR Kit (Qiagen, Osaka, Japan) under the following condimedium containing HS or FBS, the proliferation was increased to approximately seven-to ninefold in both (Fig  tions: initial denaturation for 10 min at 94°C followed by 40 cycles consisting of 15 s at 94°C and 1 min at 2, slanted striped bars), suggesting the possibility that HS may promote proliferation to the same extent as 60°C. The data analysis consisted of a fold induction, and the expression ratio was calculated from the differ-FBS, with some soluble factors. However, none of them were over that of CGM (Fig. 2, horizontal striped bar) . ences in the threshold cycles at which an increase in the reporter fluorescence above a baseline signal could first Statistical Analysis for Combinational Effects be detected among the three samples and was averaged of Soluble Factors for duplicate experiments. The sequence of primers we utilized in the real-time PCR to detect human Col2A1
We selected 12 kinds of soluble factors to be examined (Table 1) . We used a fractional factorial design to and human GAPDH were: hCol2A1 forward 5′-GAGT CAAGGGTGATCGTGGT-3′, reverse 5′-CACCTTGG determine an optimal combination with a minimal number of experiments. Using 256 kinds of media deter-TCT CCAGAAGGA-3′; hGAPDH forward 5′-GAAGG TGAAGGTCGGAGTCA-3′, reverse 5′-GAAGATGGT mined by the software JMP-5.1.1.J (Table 2) , we examined the proliferation effects in a colorimetric assay. The GATGGGATTTC-3′. hGAPDH was used as a housekeeping gene.
results obtained for the 256 kinds of media were also analyzed by the software JMP-5.1.1.J.
RESULTS
In this analysis, FGF-2, Dex, insulin, and IGF-I
Proliferation of Auricular or Costal Chondrocytes
showed parameter estimates of 0.192 (F = 676), 0.0943 With or Without FBS (F = 166), 0.0626 (F = 75.1), and 0.0524 (F = 52.6), respectively, and they showed significant effects on prolifIn a microtia operation, both remnant auricular cartilage and surgical debris of the costal cartilage, neither eration alone (p < 0.001). Eight other factors did not prominently promote proliferation of the auricular chonof which is used for reconstructive surgery, were obtained from individual patients. The mean weight was drocytes in the presence of 5% HS, and especially BMP-2 worked rather negatively in the chondrocyte prolifera-1.18 g (1.00-1.42, n = 5) or 3.60 g (2.2-5.0, n = 5), respectively, while the mean cell number of the isolated tion (parameter estimate −0.194, F = 720). Regarding synergy, the interaction term of FGF-2 and insulin and chondrocytes was 3. ). We first examined the prolifthat of FGF-2 and IGF-I exhibited statistically positive effects (parameter estimates 0.0582 and 0.0565, F = 64.3 eration of the auricular and costal chondrocytes taken from these tissues. When the commercial medium, CGM and 60.7, p < 0.001), although IGF-I and insulin decreased the effects of synergy (parameter estimate −0.0601, containing 5% FBS with an undisclosed concentration of FGF-2, IGF-I, and insulin, was used for chondrocyte F = 68.7, p < 0.001). Therefore, we chose the combinations of FGF-2 with insulin or IGF-I as ideal ones that proliferation and passage was performed every week, both kinds of chondrocytes showed exponential growth showed high F-values in both individual factors and interaction terms of two factors. Actually, the combinaafter some lag phase in all five patients. The growth rate was higher in the auricular chondrocytes than in costal tions of FGF-2 and insulin or FGF-2 and IGF-I showed high values of parameter estimates, suggesting strong efones. Figure 1 shows the typical growth curve of two patients. The auricular chondrocytes increased their fects on proliferation, when the chondrocytes were cultured together with 5% HS (Fig. 3) . number by 1000-fold within passages 3-4 (3-4 weeks), while it took more than five passages (5 weeks) for the Effects of Doses of FGF-2, Insulin, and IGF-I costal ones (Fig. 1) .
on the Synergy Next, we attempted to substitute FBS for HS and/or some other factors. When we examined the proliferation To confirm the effects of FGF-2, insulin, IGF-I, or their combinations on chondrocyte proliferation, the inof the auricular chondrocytes in the medium without any serum or soluble factors, they did not undergo proliferacrease in cell numbers was counted, following the culture in the media containing 5% HS with those factors tion at all (Fig. 2, open bar) . When we added FGF-2 and or their combination in various doses. FGF-2 showed a 2 10 ng/ml). The addition of both insulin and IGF-I to FGF-2 showed an 11-fold increase, which was somedose dependency for proliferation in the range of 10-500 ng/ml, although more than 1 µg /ml seemed to be what lower, compared with the combination of FGF-2 with insulin (12-fold) (Fig. 5 , FGF-2 10 ng/ml). The the top limit. Insulin and IGF-I did not exhibit increasing effects on proliferation in the range of 5-500 µg/ml same tendency was observed in the combination of 100 ng/ml FGF-2 with insulin, IGF-I, or both. Especially the or 100 ng-10 µg/ml, respectively (Fig. 4) .
The synergistic effects of insulin or IGF-I with FGFcombination of 100 ng/ml FGF-2 and insulin showed prominent proliferation (16-fold) (Fig. 5 , FGF-2 100 ng/ 2 seemed to be maintained until the dose of FGF-2 increased to 100 ng/ml (Fig. 5) . In the combination of 10 ml). When the dose of FGF-2 was 500 ng/ml, the addition of insulin, IGF-I, or both made little difference ng/ml FGF-2 with 5 µg/ml insulin or 100 ng/ml IGF-I, the cell number increased to approximately 12-or 10-compared with FGF-2 alone, suggesting that synergistic effects of insulin and IGF-I were not found at this dose fold, respectively, within 2 weeks, while the increase was limited to eightfold with FGF-2 alone (Fig. 5, FGF of FGF-2 (Fig. 5 , FGF-2 500 ng/ml). Although 500 ng/ . All values are presented as mean + SD. Statistics were assessed using the Student's t-test (*p < 0.05 vs. the group using FGF-2 10 ng/ml alone, **p < 0.05 vs. the group using FGF-2 100 ng/ml alone).
ml of FGF-2 alone showed higher proliferation effects 2.96 ± 1.82, 7.26 ± 4.59, 11.3 ± 7.11, and 15.5 ± 3.50, respectively. than did 100 ng/ml, the combinations of 500 ng/ml FGF-2 with insulin, IGF-I, or both showed almost the DISCUSSION same proliferation ability as those combinations with 100 ng/ml FGF-2 (Fig. 5) . These results were reproduc-
The first issue that we must achieve is to gain sufficient cell numbers of cultured chondrocytes for the cartiible in every lot of HS (data not shown).
To confirm the actual 1000-fold increase in the cell lage regenerative medicine. A previous report described that fetal elastic chondrocytes proliferated more quickly numbers, we examined a long-term culture with repeated passaging of the auricular chondrocytes in 5% than fetal hyaline cartilage (9) . In the present study, the auricular chondrocytes of school children age patients HS-DMEM/F-12 containing FGF-2 (100 ng/ml) with or without insulin (5 µg/ml) or IGF-I (100 ng/ml). A pasalso had more favorable proliferation, compared with the costal ones. In addition, we could determine an efsage was performed every other week, an interval that corresponded to the period used in the above experifective proliferation medium containing human serum or several soluble factors, showing high responsiveness to ments for determining the kinds and doses of the soluble factors. In the growth curves, all kinds of media as well the auricular chondrocytes. Also because the auricular cartilage can be accessed easily in minimally invasive as the CGM provided good proliferation after some lag phase, and realized a 1000-fold increase during passage fashion, through a simple auricle biopsy, this kind of chondrocyte would be a good candidate for a cell source 4 (Fig. 6) . Especially, the combination of FGF-2 and insulin exhibited the highest growth rate, arriving at for cartilage regenerative medicine.
In the present study, we determined the combinations 10,000-fold within passage 4.
Finally, we checked the gene expression pattern of of two factors, which promote the proliferation of human auricular chondrocyte in the presence of 5% HS, the chondrocytes proliferated in these four kinds of media. All of them showed an absolutely lower expression among 12 soluble factors, by analysis of variance in fractional factorial design. For the analysis, we did not in Col2A1, compared with chondrocytes of the primary culture (passage 0). The expression ratio was 7470 ± confine the factors to be examined to those that had been previously published to be effective for the proliferation 2450 in the primary culture, while those of a long-term culture in CGM, the medium containing FGF-2, and that of the human auricular chondrocytes, but used many factors that are reported to possess some effects on either in the combination of FGF-2 with insulin or IGF-I were sage from G 0 to G 1 at the entry in the cell cycle, while the latter correspond to insulin or IGF-I, which commit the cells to DNA synthesis (1) . The synergy of FGF-2 with insulin or IGF-I seemed to be associated with the cooperation of these competence and progression factors. In contrast, because insulin and IGF-I, which possess a common role as progression factors, did not compensate each other and could not accelerate the cell cycle effectively, the simultaneous use of both insulin and IGF-I did not help the promotion of proliferation, as seen in the present study. Further studies on signal pathways downstream of FGF-2 and insulin or IGF-I in chondrocytes are anticipated to disclose not only the detailed mechanisms of the synergistic effects of those factors but also to provide the optimal promotion of chondrocyte proliferation.
In contrast, BMP-2 worked rather negatively in the chondrocyte proliferation. In the experiment using the drive the direction to produce the cartilaginous matrix, but to arrest the progression of the cell cycles.
Regarding the doses of FGF-2, less than 10 ng/ml was used for the promotion of proliferation in chondrothe proliferation or differentiation of chondrocytes, including those derived from animals and cell lines in orcytes and MSC in many previous reports (13,25,28). Quatela and collaborators did not show that doses of der to widen the screening size. The doses of each soluble factor were those used in previous studies (Table 1) . FGF-2 greater than 100 ng/ml provide increasing effects on proliferation of human auricular chondrocytes in We confirmed the synergistic effects of FGF-2 with insulin or IGF-I in the human auricular chondrocytes monolayer culture (25). Because the capacity of a 3D culture system for cells is higher than that in a monoand proved their usefulness in combination with HS. Although it is well known that FGF-2, insulinm and IGFlayer culture, even more than 100 ng/ml FGF-2 continues to promote chondrocyte proliferation and maintain I are mitogenic to chondrocytes (13, 14, 30) , the mechanisms that promote chondrocyte proliferation seem to be the synergistic effects with insulin or IGF-I, as seen in the present data. different among such mitogens. Bohme and collaborators reported that insulin or IGF-1 could trigger chonAfter the long-term culture, which provided more than a 1000-fold increase in cell numbers, any kind of drocyte proliferation under strictly serum-free conditions, although FGF-2 did not promote cell division in media we examined equivalently brought dedifferentiation of the chondrocytes. Chondrocytes embedded in naserum-free cultures of chondrocytes (3). Quarto and coworkers also described that FGF-2 alone does not induce tive tissue synthesize type II collagen and proteoglycan, although the same cells cultured in a monolayer lose cell proliferation of chick embryonic chondrocytes without FBS (24). In contrast, FGF-2 could bolster the mitotheir typical morphology from round to a spindle fibroblast-like shape and protein synthesis, a phenomenon genic activity of FBS in cultures, indicating that the cells became conditioned by FBS so that they could respond termed dedifferentiation (29) . In order to reverse this inevitable phenomenon, many researchers have used 3D to FGF-2 (3).
This difference in the conditions in which each factor culture embedded in agarose gel (2), alginate beads (4), collagen type I gel (15), or collagen type II gel (16). expresses mitogenic activity may be explained by the general concept of competence and progression factors, However, when we applied the 3D embedded culture for chondrocyte proliferation, mRNA expression of the both of which are required to trigger cell division. The former include FGF-2, EGF, or PDGF, allowing the pasproliferated chondrocytes showed a dedifferentiation 
